Augmentation of NAD+ by NQO1 activation attenuates cisplatin-mediated hearing impairment

被引：0
|
作者：
Yang, S. [1 ]
Oh, G. S. [2 ]
Kwon, K. B. [2 ]
Park, R. K. [2 ]
Lee, S. Y. [3 ]
Moon, S. R. [4 ]
So, H. S. [2 ]
机构：
[1] Wonkwang Univ, Sch Med, Dept Internal Med, Iksan, Jeonbuk, South Korea
[2] Wonkwang Univ, Sch Med, Ctr Metab Funct Regulat, Iksan, Jeonbuk, South Korea
[3] Wonkwang Univ, Sch Med, Dept Thorac Surg, Iksan, Jeonbuk, South Korea
[4] Wonkwang Univ, Sch Med, Dept Radiat Oncol, Iksan, Jeonbuk, South Korea
来源：
EUROPEAN JOURNAL OF CANCER | 2014年 / 50卷
关键词：
D O I：
10.1016/S0959-8049(14)70290-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
164
引用
收藏
页码：55 / 55
页数：1
相关论文
共 50 条
  • [31] Modulation of NAD(P)H:Quinone oxidoreductase (NQO1) activity mediated by 5-arylamino-2-methyl-4,7-dioxobenzothiazoles and their cytotoxic potential
    Chung-Kyu Ryu
    Hyeh-Jean Jeong
    Sang Kook Lee
    Hye-Young Kang
    Kyung-Min Ko
    Yang-Jung Sun
    Eun-Ha Song
    Yeon Hoe Hur
    Chong-Ock Lee
    Archives of Pharmacal Research, 2000, 23 : 554 - 558
  • [32] Modulation of NAD(P)H:quinone oxidoreductase (NQO1) activity mediated by 5-arylamino-2-methyl-4,7-dioxobenzothiazoles and their cytotoxic potential
    Ryu, CK
    Jeong, HJ
    Lee, SK
    Kang, HY
    Ko, KM
    Sun, YJ
    Song, EH
    Hur, YH
    Lee, CO
    ARCHIVES OF PHARMACAL RESEARCH, 2000, 23 (06) : 554 - 558
  • [33] Caffeic acid phenethyl ester stimulates human antioxidant response element-mediated expression of the NAD(P)H:quinone oxidoreductase (NQO1) gene
    Jaiswal, AK
    Venugopal, R
    Mucha, J
    Carothers, AM
    Grunberger, D
    CANCER RESEARCH, 1997, 57 (03) : 440 - 446
  • [34] In vivo relevance of two critical levels for NAD(P)H:quinone oxidoreductase (NQO1)-mediated cellular protection against electrophile toxicity found in vitro
    de Haan, Laura H. J.
    Pot, Gerda K.
    Aarts, Jac M. M. J. G.
    Rietjens, Ivonne M. C. M.
    Alink, Gerrit M.
    TOXICOLOGY IN VITRO, 2006, 20 (05) : 594 - 600
  • [35] Formononetin protects against cisplatin-induced acute kidney injury through activation of the PPARα/Nrf2/HO-1/NQO1 pathway
    Hao, Yan
    Miao, Jie
    Liu, Wenjia
    Peng, Li
    Chen, Yue
    Zhong, Qing
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2021, 47 (02) : 511 - 522
  • [36] Nicotinamide-induced Mitophagy EVENT MEDIATED BY HIGH NAD+/NADH RATIO AND SIRT1 PROTEIN ACTIVATION
    Jang, So-young
    Kang, Hyun Tae
    Hwang, Eun Seong
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (23) : 19304 - 19314
  • [37] Design, synthesis, and biological evaluation of NAD(P)H: Quinone oxidoreductase (NQO1)-targeted oridonin prodrugs possessing indolequinone moiety for hypoxia-selective activation
    Xu, Shengtao
    Yao, Hong
    Pei, Lingling
    Hu, Mei
    Li, Dahong
    Qiu, Yangyi
    Wang, Guangyu
    Wu, Liang
    Yao, Hequan
    Zhu, Zheying
    Xu, Jinyi
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 132 : 310 - 321
  • [38] A novel strategy for NQO1 (NAD(P)H:quinone oxidoreductase, EC 1.6.99.2) mediated therapy of bladder cancer based on the pharmacological properties of EO9
    G A Choudry
    P A Hamilton Stewart
    J A Double
    M R L Krul
    B Naylor
    G M Flannigan
    T K Shah
    J E Brown
    R M Phillips
    British Journal of Cancer, 2001, 85 : 1137 - 1146
  • [39] A novel strategy for NQO1 (NAD(P)H:quinone oxidoreductase, EC 1.6.99.2) mediated therapy of bladder cancer based on the pharmacological properties of EO9
    Choudry, GA
    Stewart, PAH
    Double, JA
    Krul, MRL
    Naylor, B
    Flannigan, GM
    Shah, TK
    Brown, JE
    Phillips, RM
    BRITISH JOURNAL OF CANCER, 2001, 85 (08) : 1137 - 1146
  • [40] Cisplatin-mediated activation of extracellular signal-regulated kinases 1/2 (ERK1/2) by inhibition of ERK1/2 phosphatases
    Gozdz, Agata
    Vashishta, Aruna
    Kalita, Katarzyna
    Szatmari, Erzsebet
    Zheng, Jing-Juan
    Tamiya, Shigeo
    Delamere, Nicholas A.
    Hetman, Michal
    JOURNAL OF NEUROCHEMISTRY, 2008, 106 (05) : 2056 - 2067
12345